Showing results (311-320 of 457) with videos related to
Sort By:
Pageof 46
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsSatyam Chauhan, Ikran Dahir, Veena Kumari, et al.Neurochemistry International|December 3, 2021
Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementiasXin Ying Chua, Joyce R Chong, Ai Ling Cheng, et al.Journal of Alzheimer'S Disease : JAD|January 15, 2019
Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's DiseaseLutz Frölich, Alireza Atri, Clive Ballard, et al.Neurobiology of Aging|February 3, 2020
Psychosis-associated DNA methylomic variation in Alzheimer's disease cortexEhsan Pishva, Byron Creese, Adam R Smith, et al.Research in Gerontological Nursing|September 24, 2019
Nutritional Interventions for Persons With Early-Stage Dementia or Alzheimer's Disease: An Integrative ReviewIngelin Testad, Martine Kajander, Christina Tolbol Froiland, et al.International Journal of Geriatric Psychiatry|March 26, 2018
Patterns of carer distress over time in mild dementiaEllen J Svendsboe, Ingelin Testad, Toril Terum, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysisAnna Canal-Garcia, Rui M Branca, Paul T Francis, et al.Age and Ageing|May 24, 2014
Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London Care Home SurveyRobert Stewart, Matthew Hotopf, Michael Dewey, et al.Brain : a Journal of Neurology|January 12, 2018
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approachErika Bereczki, Rui M Branca, Paul T Francis, et al.Frontiers in Psychiatry|October 16, 2020
Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19Andrew P Owens, Clive Ballard, Mazda Beigi, et al.Pageof 46